XOMA Corporation (XOMA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Mar, 2026Executive summary
Annual meeting scheduled for May 21, 2026, with virtual participation available to shareholders.
Shareholders are encouraged to review proxy materials online and vote by May 20, 2026.
Voting matters and shareholder proposals
Election of seven director nominees for terms expiring in 2027.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Approval of amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan.
Approval of the 2026 Employee Stock Purchase Plan.
Advisory vote on executive compensation (say-on-pay).
Board of directors and corporate governance
Seven director nominees listed for election, with board recommending a vote for all.
Partial view of Summaries dataset, powered by Quartr API
Latest events from XOMA Corporation
- Merger proposal offers $39/share plus a litigation-tied CVR; board and major holders support approval.XOMA
Proxy filing10 Jun 2026 - All proposals, including director elections and plan approvals, passed unanimously with no questions.XOMA
AGM 202621 May 2026 - Amendment adds HoldCo to the merger, clarifies terms, and outlines key risks and approvals needed.XOMA
Proxy filing18 May 2026 - FY2025 receipts topped $50M; Q1 2026 net income $4.5M; Ligand merger and portfolio growth drive outlook.XOMA
Q1 202612 May 2026 - Acquisition of XOMA Royalty adds significant royalty assets, accelerates growth, and avoids dilution.XOMA
Proxy filing28 Apr 2026 - Ligand to acquire XOMA Royalty for $39/share plus CVR, expanding its royalty portfolio and growth.XOMA
Proxy filing27 Apr 2026 - Shareholders will vote on director elections, auditor ratification, equity plans, and executive pay.XOMA
Proxy filing30 Mar 2026 - Royalty receipts rose 68% and the portfolio doubled, fueling strong cash flow and profitability.XOMA
Q4 202518 Mar 2026 - Diversified royalty portfolio, strong cash flow, and major pipeline catalysts ahead.XOMA
Leerink Global Healthcare Conference 202611 Mar 2026